Leading the Way in Life Science Technologies

GEN Exclusives

More »

Columns

More »
Apr 1, 2010 (Vol. 30, No. 7)

IP Position Critical to Biotech Investment

Looming Battle over Gene Patenting Could Jeopardize Medical Advances

  • Takeaways: The Case for Gene Patents

    • Gene patents are the foundation of the biotech industry and precluding them would halt forward progress.
    • The patent system promotes innovation and stimulates investment in R&D.
    • If there were no exclusive rights in the final product, there would be
      little incentive to invest time and money into developing it.
    • Without the incentives offered by the issuance of patents, the industry and, ultimately, patients would suffer.



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »